CD40 ligation, when combined with T-cell-derived cytokines like IL4 and IL8, increases the survival, growth, and resistance to the standard immunochemotherapy of CLL (Figure 3) [114,115,116,117,118]. The gene discussed is IL4; the disease is B-cell chronic lymphocytic leukemia.